Related references
Note: Only part of the references are listed.Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome
Yang Yuan et al.
EBIOMEDICINE (2021)
Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome
Hao Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Kimiyasu Shiraki et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection
Mutsuyo Takayama-Ito et al.
FRONTIERS IN MICROBIOLOGY (2020)
The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan
Tsai-Lu Lin et al.
EMERGING MICROBES & INFECTIONS (2020)
Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus SFTSV in South Korea
Seok-Min Yun et al.
JCI INSIGHT (2020)
Severe Fever with Thrombocytopenia Syndrome, Japan, 2013-2017
Yusuke Kobayashi et al.
EMERGING INFECTIOUS DISEASES (2020)
Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam
Xuan Chuong Tran et al.
EMERGING INFECTIOUS DISEASES (2019)
First case of laboratory-confirmed severe fever with thrombocytopenia syndrome disease revealed the risk of SFTSV infection in Xinjiang, China
Liying Zhu et al.
EMERGING MICROBES & INFECTIONS (2019)
Clinically Relevant Concentrations of Anticancer Drugs: A Guide for Nonclinical Studies
Dane R. Liston et al.
CLINICAL CANCER RESEARCH (2017)
Peramivir injection in the treatment of acute influenza: a review of the literature
Ashley Wester et al.
INFECTION AND DRUG RESISTANCE (2016)
Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
Hideki Tani et al.
MSPHERE (2016)
Favipiravir: A New Medication for the Ebola Virus Disease Pandemic
Takashi Nagata et al.
DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS (2015)
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Jean-Francois Rossignol
ANTIVIRAL RESEARCH (2014)
The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan
Toru Takahashi et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial
Jason Haffizulla et al.
LANCET INFECTIOUS DISEASES (2014)
Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model
Zixue Shi et al.
VIROLOGY JOURNAL (2014)
Severe Fever with Thrombocytopenia Syndrome, South Korea, 2012
Kye-Hyung Kim et al.
EMERGING INFECTIOUS DISEASES (2013)
Hemorrhagic Fever Caused by a Novel Bunyavirus in China: Pathogenesis and Correlates of Fatal Outcome
Yong-Zhen Zhang et al.
CLINICAL INFECTIOUS DISEASES (2012)
Phase III Randomized, Double-Blind Study Comparing Single-Dose Intravenous Peramivir with Oral Oseltamivir in Patients with Seasonal Influenza Virus Infection
Shigeru Kohno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Fever with Thrombocytopenia Associated with a Novel Bunyavirus in China
Xue-Jie Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Anti-Hepatitis C Agent Nitazoxanide Induces Phosphorylation of Eukaryotic Initiation Factor 2α Via Protein Kinase Activated by Double-Stranded RNA Activation
Menashe Elazar et al.
GASTROENTEROLOGY (2009)
Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational Level
Jean Francois Rossignol et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
In vitro and in vivo activities of anti-influenza virus compound T-705
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
